Media
Explore our latest news, events, and resources.
From educational publications to campaign highlights and upcoming activities, this section brings together all our updates to keep patients, healthcare professionals, and advocates informed and engaged in the world of radioligand therapy.
News
- News28.01.2020
How Radiotheranostics work?
Read more - News28.01.2020
Strong potential of targeted α-therapy
Read more - News21.01.2020
Merry Christmas and Happy New Year
Read more - News15.11.2019
Happy Thanksgiving
Read more - News25.09.2019
EANM commitment: learning from the UK experience
Read more - News25.09.2019
Promising results for prostate cancer response to PRLT
Read more
Events
- Events3rd October - 26th October
Tackle Cancer Challenge
Read more - Events8th to 11th June, 2024
Join us at the SNMMI Annual Meeting 2024
Read more - Events31th May to 4th July, 2024
Meet us in ASCO at Chicago, USA
Read more - Events24-26th May, 2024
Norwegian Society for Nuclear Medicine and Molecular Imaging Spring Meeting (NSNM)
Read more - Events26-28th April, 2024
Meet us in New Zealand at ANZSNM
Read more - EventsMarch 22-24, 2024
7th Theranostics World Congress
Read more
Videos
What Are Radiotheranostics for Cancer Care?
Doctor, will Radiotheranostics make me radioactive?
Tom, treated with PRRT for NETs
Fernando Acosta’s Testimonial with Lutetium-177 PSMA Radioligand Therapy
Links
Nuclear medicine
- The NME (Nuclear medicine Europe) has implemented a website for the general public called “What is Nuclear medicine ?”, that features movies, cartoons and special small booklets to be downloaded that explain basic concepts.
- Official bodies such as EANM and SNMMI also have materials explaining aria-describedby="qtip-67">Nuclear medicine.
- You will find useful information as well on the IAEA website about Radiopharmaceuticals production and some interesting Publications regarding advances search.
Books
In order to explain this technology in an accessible way, a reference booklet containing information on Nuclear medicine was written by the author of this project. It was initially intended for workers in the Radiopharmaceutical industry but was then used for patients and finally distributed to potential investors. This book is presently available in French, English, and Spanish.